A Genetic Engineering Method for the Production of Peptide Therapeutics


Novel peptide therapeutics which specifically target to and kill certain types of  cancer cells are provided. Also an overall method for the synthesis of small, bioactive peptide therapeutics is developed using a primer-based gene synthesis approach coupled with E. Coli-based heterologous protein expression and purification. The genetic engineering method could decrease the cost of producing the novel peptide therapeutics as well as provide a method for building a peptide therapeutic library for further screening.


Patent Information:
For Information, Contact:
Arnaud Cottet
Technology Commercialization Manager
University of Notre Dame
(574) 631-9766
Shaun Lee
Clayton Thomas
Daniel Alber
© 2018. All Rights Reserved. Powered by Inteum